RESPONSE TO INFORMATIONAL CALL QUESTIONS.DD24-0064.final.docx

DoD Form DOCX document 19 KB Posted

Attached to
Surveillance of Muscular Dystrophies
Opportunity number
CDC-RFA-DD-24-0064
Issued by

About this file

This document is a Question and Answer (Q&A) response regarding the Centers for Disease Control and Prevention (CDC) funding opportunity CDC-RFA-DD-24-0064 for Surveillance of Muscular Dystrophies. The Q&A provides clarification on several key aspects of the funding opportunity, including the required data sources, the role of the data coordinating center, the page limits for applications, and the inclusion of citations/references.

The funding opportunity has three components: Component A for core surveillance and dissemination activities, Component B for abstractor training and data quality improvement, and an optional Component C to develop novel case-finding or data collection approaches. The total estimated funding is $14 million for Component A, $400,000 for Component B, and $800,000 for Component C over 4 years. The funding opportunity is part of the Birth Defects and Developmental Disabilities - Prevention and Surveillance program (CFDA 93.073) administered by the Department of Health and Human Services Centers for Disease Control and Prevention.

RESPONSE TO INFORMATIONAL CALL QUESTIONS.DD24-0064.final.docx

View the file

Other versions and copies of DD Form 24

File Revision Posted Attached to
POLAR SEA_DD_24_Attach 1_Rev3 5 Feb 2024.pdf Rev. 3, Feb 5, 2024 USCGC POLAR SEA WAGB-11 FY24 Drydock - Hull Cleaning
PSEA_DD_24_RRY_Rev3 5 Feb 2024.pdf Rev. 3, Feb 5, 2024 POLAR SEA WAGB-400 Towing and Drydock for Hull Cleaning
Rev3_CDC-RFA-DD-24-0051.pdf Rev. 3 Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults
Rev2 CDC-RFA-DD-24-0051 (9).pdf Rev. 2 Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults
CDC-RFA-DD-24-0083_NOFO_Questions_and_Answers_April 12_2024_Final.docx Apr 12, 2024 Documenting outcomes associated with Persistent Tic Disorders (including Tourette Syndrome) in Children, Adolescents, and Young Adults through Surveillance
DD24-0051 NOFO_CHDSTAR2_InfoWebinar_3.18.24_NS.pdf Mar 18, 2024 Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults
CDC-RFA-DD-24-0064 revised March 15 .pdf Mar 2015 Surveillance of Muscular Dystrophies
DD24-0065 Surveillance of Spina Bifida Across the Lifespan - FAQ.docx Revision not stated Surveillance of Spina Bifida across the Lifespan
Appendix DD24-0051.pdf Revision not stated Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults
Rev CDC-RFA-DD-24-0051 NOFO.pdf Revision not stated Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults
CDC-RFA-DD-24-0051 NOFO.pdf Revision not stated Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults
CDC-RFA-DD-24-0064.pdf Revision not stated Surveillance of Muscular Dystrophies
Foa_Content_of_CDC-RFA-DD-24-0065.pdf Revision not stated Surveillance of Spina Bifida across the Lifespan
CDC-RFA-DD-24-0083.pdf Revision not stated Documenting outcomes associated with Persistent Tic Disorders (including Tourette Syndrome) in Children, Adolescents, and Young Adults through Surveillance
DD-24-0055.pdf Revision not stated Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity Disorder (ADHD) or Tourette Syndrome (TS)
A07-W91RUS-18-R-DD24.pdf Revision not stated OPTION - Matrix switch warranty
Show all 16

Who attaches DD Form 24

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Q&A for CDC-RFA-DD-24-0064 Surveillance of Muscular Dystrophies

1. In the description you are asking for individuals with muscular dystrophy to be identified and followed longitudinally through sources such as neuromuscular, specialty care and other outpatient clinics; administrative data (e.g., vital records, Medicaid/Medicare, hospital discharge); or other sources available to funding recipients.

The state will only be able to provide administrative data at this time. Would this be acceptable, or is it required to have data from neuromuscular, specialty care and other outpatient clinics in addition to the administrative data?

Answer: It is required to have access to electronic health records from neuromuscular, specialty care, and other outpatient clinics in addition to administrative data (e.g., vital records, hospital discharge data).

2. Unlike previous funding cycles, there is no separate data coordinating center, and these activities are not included as part of Component A. Could CDC please elaborate on the plan for getting this type of work completed during the funding cycle and the expectations that a surveillance site may have for the usual and customary activities of a data coordinating center?

Answer: The data coordinating center will be housed at CDC. Activities of the data coordinating center will include, but are not limited to, providing standardized database(s), data documentation and manuals, pooled datasets, and technical assistance to sites.

3. Can a different PI be proposed for Comp B/C then for Comp A?

Answer: There will be one principal investigator (PI) assigned as the primary PI for the cooperative agreement. However, in your application you can indicate different staff (e.g., co-PIs) who will be responsible for different components or activities. The final cooperative agreement will reflect the primary PI’s information.

4. If we are applying for multiple components, is 4 pages the limit for the project narrative including the wok plan for Comp B and/or C?

Answer: Applications that include more than one component can use 15 pages as the base allotted pages and add up to 4 additional pages to that per additional component included. For example, 4 pages for the project narrative would be specific to that component. It also includes the workplan for that component. Content beyond specified limits may not be reviewed. See the answer to Question 5 below for more details regarding page limits.

5. I have a question related to the page limit of the NOFO CDC-RFA-DD-24-0064Rev.3.15.2024.

On Page 28 under Section 10. Project narrative, the NOFO reads: “Multi-component NOFOs may have a maximum of 15 pages for the “base” (subsections of the Project Description that the components share with each other, which may include target population, inclusion, collaboration, etc.); and up to 4 additional pages per component for Project Narrative subsections that are specific to each component.

The presentation done on the Information call on Thursday, 3/28 mentioned:

- 15 pages maximum for base project description Max 15 pages, single-spaced, 12 pt font,

- 4 additional pages per component for subsections specific to each component

So to make sure that we do not misunderstand the requirements, could you please clarify the following:

1. Component A

- If an applicant applies for Component A only, then would the limit be 15 pages?

OR

- If an applicant applies for Component A only, then would the limit be 19 pages? (15 pages for the “base”+4 pages for Comp A)

2. Components A and B

- If an applicant applies for Components A and B, then would the limit be 19 pages? (15 pages for Comp A+4 pages for Comp B)

OR

- If an applicant applies for Component A and B, then would the limit be 23 pages? (15 pages for the “base”+4 pages for Comp A+4 pages for Comp B)

3. Components A and B and C

- If an applicant applies for Components A and B and C, then would the limit be 23 pages? (15 pages for Comp A+4 pages for Comp B+4 pages for Comp C)

OR

- If an applicant applies for Component A and B and C, then would the limit be 27 pages? (15 pages for the “base”+4 pages for Comp A+4 pages for Comp B+4 pages for Comp C)

Answer:

1. If an applicant applies for Component A only, the page limit is 19 pages.

2. If an applicant applies for Components A and B, the page limit is 23 pages.

3. If an applicant applies for Components A, B, and C, the page limit is 27 pages.

6. I am writing to ask you question regarding Appendices for CDC-RFA-DD-24-0064 application. Are citations lists an allowable appendix? If so, what should the filename be and where it should be uploaded?

Answer: Page 46, under the NOFO section H. Other Information, states, “Applicants may not attach documents other than those listed; if other documents are attached, applications will not be reviewed.” As the list does not include references, these should be included in the project narrative.

File details come from the government source that posted it. Updated .